It is our pleasure to announce an alternative protocol for our NucleoBond RS product series, which was released in September 2023!
The new protocol works without the animal-derived RNase A. Using materials of animal origin in regulated environments is potentially harmful to the development and production of health-sensitive products, like gene and cell therapeutics.
For more information, check out the supplementary protocol here!
